Skip to main content

Table 4 Differences between recommendations by change status

From: Updated recommendations: an assessment of NICE clinical guidelines

  New-replaced recommendations Not changed recommendations Pa
(cases, n = 78) (controls, n = 27)
CGs, n (%)
- Anaemia management in chronic kidney disease 1 (1.3) - - 0.036
- Caesarean section 10 (12.8) 1 (3.7)
- Chronic heart failure 4 (5.1) 4 (14.8)
- Chronic obstructive pulmonary disease - - - -
- Epilepsy 2 (2.6) 5 (18.5)
- Fertility 34 (43.6) 10 (37.0)
- Head injury 3 (3.8) - -
- Infection control 24 (30.8) 7 (25.9)
- Lung cancer - - - -
Time between publication versions, median (range)
- Years 8.8 (4.3-9.0) 8.8 (7.1-9.0) 0.296
CGs topic, n (%)
- Blood and immune system/Urogenital 1 (1.3) - - 0.027
- Cardiovascular 4 (5.1) 4 (14.8)
- Central nervous system 2 (2.6) 5 (18.5)
- Gynaecology, pregnancy and birth 44 (56.4) 11 (40.7)
- Injuries, accidents and wounds 3 (3.8) - -
- Public health 24 (30.8) 7 (25.9)
- Respiratory - - - -
Recommendations purpose, n (%)
- Access to services - Referral and approach to care - Service organisation 3 (3.8) 2 (7.4) 0.027
- Diagnostic 7 (9.0) 1 (3.7)
- Monitoring - Follow up 1 (1.3) 5 (18.5)
- Prevention practices 23 (29.5) 7 (25.9)
- Supporting patients and carers 17 (21.8) 2 (7.4)
- Treatment 23 (29.5) 9 (33.3)
- >1 procedure - Others 4 (5.1) 1 (3.7)
Recommendations strength - SIGN, n (%)
- A 25 (32.1) 6 (22.2) 0.296
- B 5 (6.4) 2 (7.4)
- C 11 (14.1) 5 (18.5)
- D 19 (24.4) 7 (25.9)
- GPP 16 (20.5) 6 (22.2)
- Others 2 (2.6) 1 (3.7)
  1. Abbreviations: CG Clinical guidelines, GPP Good practice point.
  2. aPearson Chi-Square or Mann-Whitney Test, as appropriate.